Low prevalence of human herpesvirus-6 and varicella zoster virus in blood of multiple sclerosis patients, irrespective of inflammatory status or disease progression

• Published in: Journal of clinical neuroscience Vol. 21; no. 8; pp. 1437 - 1440
• Main Authors: Hon, Gloudina M., Erasmus, Rajiv T., Matsha, Tandi
• Format: Journal Article
• Language: English
• Published: Scotland Elsevier Ltd 01.08.2014
• Subjects: C-reactive protein; C-Reactive Protein - metabolism; Disease Progression; DNA, Viral - blood; European Continental Ancestry Group; Herpesvirus 3, Human - genetics; Herpesvirus 6, Human - genetics; Human herpesvirus 6; Humans; Middle Aged; Multiple sclerosis; Multiple Sclerosis - blood; Multiple Sclerosis - epidemiology; Multiple Sclerosis - immunology; Neurology; Polymerase Chain Reaction; Prevalence; Varicella zoster virus; Varicella zoster virus; Human herpesvirus-6; Multiple sclerosis; C-reactive protein
• ISSN: 0967-5868; 1532-2653; 1532-2653
• DOI: 10.1016/j.jocn.2013.10.027

Herpesviruses, including human herpesvirus-6 and varicella zoster virus, have been implicated in the disease aetiology of multiple sclerosis. These viruses are capable of reactivation, reminiscent of the relapsing-remitting nature of multiple sclerosis. However, viral DNA has also been reported present in healthy controls, often at similar prevalence rates. This study aimed to determine whether prevalence could be associated with different stages of activity of the disease as well as the inflammatory status of the patients. Polymerase chain reaction assays were used to screen for human herpesvirus-6 and varicella zoster virus DNA in blood from 31 Caucasian patients with multiple sclerosis and 30 healthy age, sex and race matched control subjects. The patients were screened for inflammation using C-reactive protein as a marker and were also categorized according to their remitting/relapsing status. Results were positive for human herpesvirus-6 in blood from only one patient (3.2%) and human herpesvirus-6 DNA was not present in any control subjects. Varicella zoster virus was not detected in either the patients or control subjects. Similar to some other studies we saw an absence or very low viral positivity in blood from both patients and controls. These findings were irrespective of relapse episodes, increased inflammatory status or duration of the disease. Results therefore do not support a causative role for either human herpesvirus-6 or varicella zoster virus in the disease aetiology of multiple sclerosis, but rather that prevalence in patients may be linked to that of the general population.